Home LiteratureArticle Details
PMID: 8460169 Published · ppublish English Journal Article

Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Brown K, Park S, Kanno T, Franzoso G, Siebenlist U

Abstract

The NK-kappa B transcription factor complex is sequestered in the cytoplasm by the inhibitory protein I kappa B-alpha (MAD-3). Various cellular stimuli relieve this inhibition by mechanisms largely unknown, leading to NF-kappa B nuclear localization and transactivation of its target genes. It is demonstrated here with human T lymphocytes and monocytes that different stimuli, including tumor necrosis factor alpha and phorbol 12-myristate 13-acetate, cause rapid degradation of I kappa B-alpha, with concomitant activation of NF-kappa B, followed by a dramatic increase in I kappa B-alpha mRNA and protein synthesis. Transfection studies reveal that the I kappa B-alpha mRNA and the encoded protein are potently induced by NF-kappa B and by homodimers of p65 and of c-Rel. We propose a model in which NF-kappa B and I kappa B-alpha mutually regulate each other in a cycle: saturating amounts of the inhibitory I kappa B-alpha protein are destroyed upon stimulation, allowing rapid activation of NF-kappa B. Subsequently, I kappa B-alpha mRNA and protein levels are quickly induced by the activated NF-kappa B. This resurgence of I kappa B-alpha protein acts to restore an equilibrium in which NF-kappa B is again inhibited.

MeSH Terms
Blotting, Northern Cell Line Cell Nucleus/drug effects,physiology DNA-Binding Proteins/genetics,metabolism Gene Expression Regulation/drug effects Humans I-kappa B Proteins Ionomycin/pharmacology Macromolecular Substances Monocytes/immunology NF-kappa B/antagonists & inhibitors,metabolism RNA, Messenger/metabolism T-Lymphocytes/immunology Tetradecanoylphorbol Acetate/pharmacology Transfection Tumor Necrosis Factor-alpha/pharmacology
Chemicals
DNA-Binding Proteins I kappa B beta protein I-kappa B Proteins Macromolecular Substances NF-kappa B RNA, Messenger Tumor Necrosis Factor-alpha Ionomycin Tetradecanoylphorbol Acetate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Brown K
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Park S
Kanno T
Franzoso G
Siebenlist U
References (44)
44 references, click to expand
  1. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  2. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  3. Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel.
    J Virol. 1984 Oct;52(1):172-82 PMID: 6090694
  4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  5. Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.
    Science. 1987 Oct 30;238(4827):692-4 PMID: 3118464
  6. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.
    Cell. 1988 Apr 22;53(2):211-7 PMID: 3129195
  7. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  8. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.
    Oncogene. 1989 Jul;4(7):935-42 PMID: 2666912
  9. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
    Genes Dev. 1989 Nov;3(11):1689-98 PMID: 2691328
  10. Avian reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59v-rel complexes.
    J Virol. 1990 Feb;64(2):584-91 PMID: 2153225
  11. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  12. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA.
    Cell. 1990 Apr 20;61(2):255-65 PMID: 2184941
  13. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
    Cell. 1990 Sep 7;62(5):1007-18 PMID: 2203531
  14. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
    Cell. 1990 Sep 7;62(5):1019-29 PMID: 2203532
  15. Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
    Nature. 1990 Nov 1;348(6296):76-80 PMID: 2234062
  16. NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):10028-32 PMID: 2263603
  17. Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli.
    Mol Cell Biol. 1991 Jan;11(1):259-66 PMID: 1986224
  18. Sex, maps, and imprinting.
    Cell. 1991 Jan 11;64(1):1-3 PMID: 1986861
  19. The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity.
    Genes Dev. 1990 Nov;4(11):1975-84 PMID: 2125960
  20. Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.
    Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):966-70 PMID: 1992489
  21. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Cell. 1991 Mar 8;64(5):961-9 PMID: 2001591
  22. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
    Science. 1991 Mar 22;251(5000):1490-3 PMID: 2006423
  23. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.
    Biochim Biophys Acta. 1991 Apr 16;1072(1):63-80 PMID: 2018779
  24. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
    EMBO J. 1991 Jul;10(7):1817-25 PMID: 2050119
  25. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  26. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  27. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Nature. 1991 Aug 22;352(6337):733-6 PMID: 1876189
  28. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
    Science. 1991 Sep 13;253(5025):1268-71 PMID: 1891714
  29. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    EMBO J. 1991 Dec;10(12):3805-17 PMID: 1935902
  30. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
    Cell. 1991 Dec 20;67(6):1075-87 PMID: 1760839
  31. Purified I kappa B-beta is inactivated upon dephosphorylation.
    J Biol Chem. 1992 Jan 5;267(1):239-46 PMID: 1309735
  32. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
    Mol Cell Biol. 1992 Feb;12(2):674-84 PMID: 1732739
  33. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
    Mol Cell Biol. 1992 Feb;12(2):685-95 PMID: 1531086
  34. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1875-9 PMID: 1542686
  35. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Genes Dev. 1992 May;6(5):745-60 PMID: 1577270
  36. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4333-7 PMID: 1533932
  37. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
    Mol Cell Biol. 1992 Jun;12(6):2898-908 PMID: 1588976
  38. The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.
    Nucleic Acids Res. 1992 May 25;20(10):2453-8 PMID: 1598203
  39. Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells.
    J Clin Invest. 1992 Jul;90(1):121-9 PMID: 1634604
  40. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
    DNA Cell Biol. 1992 Sep;11(7):523-37 PMID: 1388725
  41. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Genes Dev. 1992 Oct;6(10):1899-913 PMID: 1340770
  42. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
    Nature. 1992 Sep 24;359(6393):339-42 PMID: 1406939
  43. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
    EMBO J. 1993 Jan;12(1):201-11 PMID: 7679069
  44. Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
    Proc Natl Acad Sci U S A. 1983 Oct;80(20):6229-33 PMID: 6312449
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1993-03-15
Pages
2532-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC46122
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]